Doyle Wealth Management Biomarin Pharmaceutical Inc Transaction History

Doyle Wealth Management

  • $1.16 Billion
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 05, 2019
SELL
$67.4 - $85.11 $20,220 - $25,533
-300 Closed
0 $0
Q2 2019

Aug 15, 2019
BUY
$80.35 - $93.9 $24,105 - $28,170
300 New
300 $26,000
Q1 2019

May 13, 2019
SELL
$84.2 - $98.62 $25,260 - $29,586
-300 Closed
0 $0
Q4 2018

Feb 08, 2019
BUY
$80.14 - $106.07 $24,042 - $31,820
300 New
300 $26,000

Others Institutions Holding BMRN

# of Institutions
623
Shares Held
181M
Call Options Held
1.73M
Put Options Held
1.73M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $15.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Doyle Wealth Management Portfolio

Follow Doyle Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Doyle Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Doyle Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email